Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase II study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage III non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306.
Sekine I, Nishiwaki Y, Ogino T, Yokoyama A, Saito M, Mori K, Tsukiyama I, Tsuchiya S, Hayakawa K, Yoshimura K, Ishizuka N, Saijo N. Sekine I, et al. Among authors: ogino t. J Clin Oncol. 2002 Feb 1;20(3):797-803. doi: 10.1200/JCO.2002.20.3.797. J Clin Oncol. 2002. PMID: 11821463 Clinical Trial.
Nonrandomized comparison between definitive chemoradiotherapy and radical surgery in patients with T(2-3)N(any) M(0) squamous cell carcinoma of the esophagus.
Hironaka S, Ohtsu A, Boku N, Muto M, Nagashima F, Saito H, Yoshida S, Nishimura M, Haruno M, Ishikura S, Ogino T, Yamamoto S, Ochiai A. Hironaka S, et al. Among authors: ogino t. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):425-33. doi: 10.1016/s0360-3016(03)00585-6. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957254
A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).
Ishikura S, Ohe Y, Nihei K, Kubota K, Kakinuma R, Ohmatsu H, Goto K, Niho S, Nishiwaki Y, Ogino T. Ishikura S, et al. Among authors: ogino t. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1117-22. doi: 10.1016/j.ijrobp.2004.07.692. Int J Radiat Oncol Biol Phys. 2005. PMID: 15752891 Clinical Trial.
1,122 results